Boxer Capital’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,497,700
Closed -$5.41M 61
2023
Q3
$5.41M Buy
6,497,700
+3,160,772
+95% +$3.64M 0.29% 50
2023
Q2
$4M Hold
3,336,928
0.19% 57
2023
Q1
$4.21M Hold
3,336,928
0.21% 55
2022
Q4
$7.24M Sell
3,336,928
-235,000
-7% -$1.93M 0.38% 45
2022
Q3
$42.8M Buy
3,571,928
+1,109,570
+45% +$13.8M 2.41% 12
2022
Q2
$20.6M Hold
2,462,358
1.31% 28
2022
Q1
$21.4M Hold
2,462,358
1.1% 28
2021
Q4
$27.8M Hold
2,462,358
1.08% 24
2021
Q3
$31M Sell
2,462,358
-100,000
-4% -$921K 1.08% 27
2021
Q2
$20.8M Hold
2,562,358
0.73% 41
2021
Q1
$23.7M Hold
2,562,358
0.8% 38
2020
Q4
$24.8M Hold
2,562,358
0.8% 36
2020
Q3
$31.8M Hold
2,562,358
1.1% 24
2020
Q2
$33.3M Buy
2,562,358
+377,358
+17% +$4.75M 1.46% 22
2020
Q1
$22.2M Hold
2,185,000
1.51% 20
2019
Q4
$34.2M Buy
2,185,000
+110,000
+5% +$2.22M 1.93% 13
2019
Q3
$34.8M Buy
2,075,000
+200,000
+11% +$3.98M 2.53% 14
2019
Q2
$41.6M Hold
1,875,000
3.58% 10
2019
Q1
$40.6M Buy
+1,875,000
New +$39.1M 4.7% 7

Other funds holding GOSS

Boxer Capital's GOSS Position: Q4 2023 in Review

Boxer Capital sold out of Gossamer Bio (GOSS) in Q4 2023, closing a stake of 6,497,700 shares — an estimated $5.41M sold.

Boxer Capital first reported a position in GOSS in Q1 2019 and held it in 19 quarters. The position peaked at $42.8M in Q3 2022. 98 funds tracked by Wall St. Rank hold GOSS as of Q4 2023.

  • Boxer Capital reported no remaining Gossamer Bio position as of Q4 2023 after selling out during the quarter.
  • Boxer Capital sold 6,497,700 Gossamer Bio shares in Q4 2023, an estimated $5.41M.
  • Boxer Capital first reported a position in Gossamer Bio in Q1 2019 and held it in 19 quarters.
  • Boxer Capital's Gossamer Bio position peaked at $42.8M in Q3 2022.
  • 98 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2023.

Based on Boxer Capital's 13F filing for Q4 2023, filed 14 Feb 2024.